Meeting
2023 ASCO Annual Meeting
Impact of WNT/B-catenin alterations and metastasis location among patients with metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICI) combinations.
Authors
Javier Ros Montañá
Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain
Javier Ros Montañá , Iosune Baraibar , Victor Navarro Garces , Nadia Saoudi Gonzalez , Sharela Vega , Sergio Bueno , Ariadna Garcia , Francesc Salva , Raquel Comas , Marta Rodríguez Castells , Omar Saavedra , Guzman Alonso , Elena Garralda , Josep Tabernero , Ana Vivancos , Elena Elez
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3573)
DOI
10.1200/JCO.2023.41.16_suppl.3573
Abstract #
3573
Poster Bd #
273
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Predictive biomarkers for response to immunotherapy in patients with deficient DNA mismatch repair metastatic colorectal cancer.
First Author: Amos Stemmer
Poster
2020 Gastrointestinal Cancers Symposium
Wild-type APC and prognosis in metastatic colorectal cancer.
First Author: Chongkai Wang
Poster
2019 ASCO Annual Meeting
Influence of WNT and DNA damage response pathway alterations on outcomes in patients with unresectable metastatic colorectal cancer.
First Author: Sebastian Mondaca
Poster
2023 ASCO Genitourinary Cancers Symposium
Genomic determinants of patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer.
First Author: Philip Sutera